The Trigeminal Nerve: Why Migraine Pain Shows Up Where It Does
Migraine pain has a very specific anatomical reason for showing up behind your eye, across your forehead, or down your jaw. It all traces back to one nerve. Here's how the trigeminal nerve drives the pain — and why it's the target of the newest migraine medications.
If you've ever wondered why a migraine seems to settle in such oddly specific places — one eye socket, one temple, a band across the forehead, sometimes even the teeth or jaw — there's a real anatomical reason for that. It's not random, and it's not "just a headache." It's the trigeminal nerve doing exactly what it's built to do, just in overdrive.
Understanding this nerve doesn't just satisfy curiosity. It explains why migraine pain feels the way it does, why certain treatments work, and why some of the newest migraine drugs were designed around this exact pathway.
What the Trigeminal Nerve Actually Does
The trigeminal nerve is the largest of the twelve cranial nerves, and it's responsible for sensation across most of your face and head. It splits into three major branches — ophthalmic (forehead, eye, scalp), maxillary (cheek, upper jaw, nose), and mandibular (lower jaw, chin) — which is why migraine pain can show up in such a wide variety of locations depending on which branch is most involved.
On a normal day, this nerve is just relaying everyday sensory information: a gust of cold air on your face, the pressure of your sunglasses, the feeling of chewing. During a migraine, something very different happens.
The Trigeminovascular System: Where Pain Actually Comes From
Migraine pain isn't generated inside the brain tissue itself — the brain has no pain receptors. Instead, it comes from the network of blood vessels and membranes (the meninges) that surround the brain, and the trigeminal nerve fibers that wrap around those vessels. This combined network is often called the trigeminovascular system.
During a migraine attack, these trigeminal nerve fibers become activated and inflamed. They release inflammatory chemicals — most notably a molecule called CGRP (calcitonin gene-related peptide) — that cause blood vessels in the meninges to dilate and become inflamed. This is sometimes described as "neurogenic inflammation," and it's a big part of why migraine pain has that throbbing, pulsing quality that worsens with movement, bending over, or coughing.
The activated trigeminal nerve then sends that pain signal up to the brainstem and on to areas of the brain that process pain, which is how a problem that starts around your blood vessels translates into the experience of a pounding headache.
Why CGRP Became the Biggest Story in Migraine Treatment
For decades, migraine treatment was mostly trial and error — beta blockers, antidepressants, anti-seizure medications, all originally developed for other conditions and repurposed because they happened to help some people. The discovery of CGRP's role in the trigeminovascular system changed that.
Because CGRP is released specifically by activated trigeminal nerve fibers and plays such a direct role in the inflammation and pain cascade, it became a precise target. This led to an entire new class of medications — CGRP inhibitors, available both as acute treatments (taken during an attack) and preventives (taken regularly to reduce attack frequency). These drugs were the first migraine-specific treatments developed from the ground up based on the underlying mechanism, rather than discovered by accident.
If you've heard your doctor mention CGRP medications, this is the biology behind why they exist — and why they target this nerve pathway specifically rather than acting more broadly like older medications.
Trigeminal Sensitization: Why Migraines Can Get Worse Over Time
One of the more important concepts tied to this nerve is sensitization. With repeated migraine attacks, the trigeminal nerve pathway can become progressively more reactive — meaning it takes less and less of a trigger to set off the same cascade. This is part of the reason why some people experience allodynia during an attack, where ordinary sensations like a hairbrush touching the scalp, glasses resting on the nose, or a shirt collar against the neck become painful.
It's also part of the reasoning behind treating migraines early. The sooner an attack is interrupted — ideally during the early prodrome or mild pain stage — the less time the trigeminal pathway spends in that highly activated, inflamed state, and the easier it tends to be to bring under control.
How This Connects to Triggers You Already Know About
Many common migraine triggers make more sense once you understand this pathway. Bright light, certain smells, and barometric pressure changes don't directly cause pain — they're thought to lower the threshold at which the trigeminovascular system activates, making the trigeminal nerve more likely to fire in response to whatever the underlying buildup happens to be.
That's part of why tracking patterns over time matters so much. If you can see that your attacks cluster around specific pressure drops, sleep disruptions, or sensory exposures, you're essentially mapping out what tends to push your trigeminal system past its threshold. Our Personal Pressure Threshold Estimator is built around exactly this idea — helping you find the point where weather changes start tipping things over for you specifically.
What MigraineCast Does With This Information
You can't directly measure trigeminal nerve activity at home, but you can track the environmental conditions that tend to correlate with it firing — pressure drops, temperature swings, and humidity changes chief among them. MigraineCast monitors those conditions for your location and gives you advance notice when they're stacking up in a way that's historically preceded your attacks.
The goal isn't to explain away your pain as "just nerves." It's the opposite — understanding that this is a real, physical, measurable process is what makes it possible to intervene early, before the trigeminovascular system fully ramps up and the attack becomes harder to stop.
Track your attacks alongside weather and pressure data to see when your trigeminovascular system is most likely to be triggered. Download MigraineCast free on iOS.
Frequently Asked Questions
What is the trigeminal nerve's role in migraine?
The trigeminal nerve is the largest cranial nerve and the main pain-signaling pathway of the face and head. During a migraine, its fibers become activated and inflamed, releasing CGRP (calcitonin gene-related peptide) and other inflammatory chemicals that cause blood vessels in the brain's membranes to dilate. This neurogenic inflammation produces the throbbing headache and explains why migraine pain appears in specific locations — eye socket, temple, forehead — corresponding to the nerve's three branches.
What is CGRP and why does it matter for migraine treatment?
CGRP (calcitonin gene-related peptide) is a molecule released by activated trigeminal nerve fibers that drives inflammation and pain during a migraine attack. Because of its central role, it became the target of a new class of migraine-specific medications — CGRP inhibitors — available both as acute treatments (gepants like rimegepant) and preventives (monoclonal antibodies like erenumab). These are the first migraine drugs designed from the ground up around the underlying mechanism rather than discovered by accident.
Why does migraine pain concentrate behind one eye?
The trigeminal nerve splits into three branches covering different parts of the face and head. The ophthalmic branch (V1) serves the forehead, eye, and scalp — which is why so many migraines center behind or around one eye. The one-sided nature of migraine pain also reflects the fact that the trigeminovascular system typically activates more strongly on one side during a given attack, though the dominant side can vary between attacks.